These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
241 related items for PubMed ID: 16673687
1. Value of magnetic resonance cholangiopancreatography in the diagnosis of biliary abnormalities in postcholecystectomy patients: a probabilistic cost-effectiveness analysis of diagnostic strategies. Howard K, Lord SJ, Speer A, Gibson RN, Padbury R, Kearney B. Int J Technol Assess Health Care; 2006; 22(1):109-18. PubMed ID: 16673687 [Abstract] [Full Text] [Related]
2. Where do ERCP, endoscopic ultrasound, magnetic resonance cholangiopancreatography, and intraoperative cholangiography fit in the management of acute biliary pancreatitis? A decision analysis model. Arguedas MR, Dupont AW, Wilcox CM. Am J Gastroenterol; 2001 Oct; 96(10):2892-9. PubMed ID: 11693323 [Abstract] [Full Text] [Related]
3. The roles of magnetic resonance and endoscopic retrograde cholangiopancreatography (MRCP and ERCP) in the diagnosis of patients with suspected sclerosing cholangitis: a cost-effectiveness analysis. Meagher S, Yusoff I, Kennedy W, Martel M, Adam V, Barkun A. Endoscopy; 2007 Mar; 39(3):222-8. PubMed ID: 17385107 [Abstract] [Full Text] [Related]
4. Cost-effectiveness analysis of endoscopic ultrasound versus magnetic resonance cholangiopancreatography in patients with suspected common bile duct stones. Morris S, Gurusamy KS, Sheringham J, Davidson BR. PLoS One; 2015 Mar; 10(3):e0121699. PubMed ID: 25799113 [Abstract] [Full Text] [Related]
5. A systematic review and economic evaluation of magnetic resonance cholangiopancreatography compared with diagnostic endoscopic retrograde cholangiopancreatography. Kaltenthaler E, Vergel YB, Chilcott J, Thomas S, Blakeborough T, Walters SJ, Bouchier H. Health Technol Assess; 2004 Mar; 8(10):iii, 1-89. PubMed ID: 14982656 [Abstract] [Full Text] [Related]
6. Making cost-effectiveness analyses clinically relevant: the effect of provider expertise and biliary disease prevalence on the economic comparison of alternative diagnostic strategies. Carlos RC, Scheiman JM, Hussain HK, Song JH, Francis IR, Fendrick AM. Acad Radiol; 2003 Jun; 10(6):620-30. PubMed ID: 12809415 [Abstract] [Full Text] [Related]
7. MRCP is not a cost-effective strategy in the management of silent common bile duct stones. Epelboym I, Winner M, Allendorf JD. J Gastrointest Surg; 2013 May; 17(5):863-71. PubMed ID: 23515912 [Abstract] [Full Text] [Related]
8. Comparison Costs of ERCP and MRCP in Patients with Suspected Biliary Obstruction Based on a Randomized Trial. Adam V, Bhat M, Martel M, da Silveira E, Reinhold C, Valois E, Barkun JS, Barkun AN. Value Health; 2015 Sep; 18(6):767-73. PubMed ID: 26409603 [Abstract] [Full Text] [Related]
18. Endoscopic ultrasound versus magnetic resonance cholangiopancreatography for the diagnosis of computed tomography-negative common bile duct stone: Prospective randomized controlled trial. Suzuki M, Sekino Y, Hosono K, Yamamoto K, Kawana K, Nagase H, Kubota K, Nakajima A. Dig Endosc; 2022 Jul; 34(5):1052-1059. PubMed ID: 34784076 [Abstract] [Full Text] [Related]